Sponsors: []Modifications: (1) (a)  The division shall implement on a statewide basis, including non-residentpharmacies as defined in Section 58-17b-102, a program of:(i)  real-time submission of the information required to be submitted under this part tothe controlled substance database; and(ii)  24-hour daily batch submission of the information required to be submitted underthis part to the controlled substance database.(b)  The division shall comply with Title 63G, Chapter 6a, Utah Procurement Code.(2)(3)(2)(4)submission requirements under this part,including(5)(a)(b)(c)(5)(5)(5)(5)information(3)  All costs associated with accessing the information contained in the controlledsubstance database shall be assumed by the accessing pharmacy, pharmaceutical facility, orprescribing practitioner.Under the terms and conditions of Title 63J, Chapter 1, Budgetary Procedures Act, forthe fiscal year beginning July 1, 2015, and ending June 30, 2016, the following sums of moneyare appropriated from resources not otherwise appropriated, or reduced from amountspreviously appropriated, out of the funds or accounts indicated.  These sums of money are inaddition to any amounts previously appropriated for fiscal year 2016.To Department of Commerce - Division of Occupational and Professional LicensingFrom General Fund$46,000322               Schedule of Programs:323                    Controlled Substance Database               $46,000324          Section 6.  Effective date.325          This bill takes effect on July 1, 2015.Legislative Review Note     as of   2-23-15  4:33 PMOffice of Legislative Research and General Counsel
Schedule of Programs:Controlled Substance Database               $46,000This bill takes effect on July 1, 2015.Full text:



1     CONTROLLED SUBSTANCE DATABASE AMENDMENTS2     2015 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Edward H. Redd5     Senate Sponsor:  ____________6      7     LONG TITLE8     General Description:9          This bill modifies provisions of the Controlled Substance Database Act.10     Highlighted Provisions:11          This bill:12                requires the Division of Occupational and Professional Licensing to implement a13     program for:14                     real-time submission of data into the controlled substance database; and15                     24-hour daily batch submission of data;16                authorizes additional rulemaking authority;17                provides that those accessing data from the database are responsible for costs18     associated with accessing the data;19                repeals provisions of a pilot program; and20                makes technical corrections.21     Money Appropriated in this Bill:22          This bill appropriates in fiscal year 2016:23                to the Department of Commerce - Division of Occupational and Professional24     Licensing - Controlled Substance Database, as an ongoing appropriation:25                     from the General Fund, $46,000.26     Other Special Clauses:27          This bill provides a special effective date.28     Utah Code Sections Affected:29     AMENDS:30          58-37f-203, as last amended by Laws of Utah 2014, Chapter 7231          58-37f-301, as last amended by Laws of Utah 2014, Chapters 68 and 40132          58-37f-501, as enacted by Laws of Utah 2010, Chapter 287 and last amended by33     Coordination Clause, Laws of Utah 2010, Chapter 28734     REPEALS:35          58-37f-801, as last amended by Laws of Utah 2013, Chapter 16736      37     Be it enacted by the Legislature of the state of Utah:38          Section 1.  Section 58-37f-203 is amended to read:39          58-37f-203. Submission, collection, and maintenance of data.40          (1) (a)  The division shall implement on a statewide basis, including non-resident41     pharmacies as defined in Section 58-17b-102, a program of:42          (i)  real-time submission of the information required to be submitted under this part to43     the controlled substance database; and44          (ii)  24-hour daily batch submission of the information required to be submitted under45     this part to the controlled substance database.46          (b)  The division shall comply with Title 63G, Chapter 6a, Utah Procurement Code.47          [(1)] (2) (a)  The pharmacist in charge of the drug outlet where a controlled substance is48     dispensed shall submit the data described in this section to the division:49          (i)  in accordance with the requirements of this section;50          (ii)  in accordance with the procedures established by the division; and51          (iii)  in the format established by the division.52          (b)  A dispensing medical practitioner licensed under Chapter 17b, Part 8, Dispensing53     Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, shall comply with54     the provisions of this section and the dispensing medical practitioner shall assume the duties of55     the pharmacist under this chapter.56          [(2)] (3)  The pharmacist described in Subsection [(1)] (2) shall, for each controlled57     substance dispensed by a pharmacist under the pharmacist's supervision other than those58     dispensed for an inpatient at a health care facility, submit to the division the following59     information:60          (a)  the name of the prescribing practitioner;61          (b)  the date of the prescription;62          (c)  the date the prescription was filled;63          (d)  the name of the individual for whom the prescription was written;64          (e)  positive identification of the individual receiving the prescription, including the65     type of identification and any identifying numbers on the identification;66          (f)  the name of the controlled substance;67          (g)  the quantity of the controlled substance prescribed;68          (h)  the strength of the controlled substance;69          (i)  the quantity of the controlled substance dispensed;70          (j)  the dosage quantity and frequency as prescribed;71          (k)  the name of the drug outlet dispensing the controlled substance;72          (l)  the name of the pharmacist dispensing the controlled substance; and73          (m)  other relevant information as required by division rule.74          [(3) (a)] (4)  The division shall make rules, in accordance with Title 63G, Chapter 3,75     Utah Administrative Rulemaking Act, to establish submission requirements under this part,76     including the electronic format in which the information required under this section shall be77     submitted to the division.78          [(b)] (5)  The division shall ensure that the database system records and maintains for79     reference:80          [(i)] (a)  the identification of each individual who requests or receives information from81     the database;82          [(ii)] (b)  the information provided to each individual; and83          [(iii)] (c)  the date and time that the information is requested or provided.84          Section 2.  Section 58-37f-301 is amended to read:85          58-37f-301. Access to database.86          (1)  The division shall make rules, in accordance with Title 63G, Chapter 3, Utah87     Administrative Rulemaking Act, to:88          (a)  effectively enforce the limitations on access to the database as described in this89     part; and90          (b)  establish standards and procedures to ensure accurate identification of individuals91     requesting information or receiving information without request from the database.92          (2)  The division shall make information in the database and information obtained from93     other state or federal prescription monitoring programs by means of the database available only94     to the following individuals, in accordance with the requirements of this chapter and division95     rules:96          (a)  personnel of the division specifically assigned to conduct investigations related to97     controlled substance laws under the jurisdiction of the division;98          (b)  authorized division personnel engaged in analysis of controlled substance99     prescription information as a part of the assigned duties and responsibilities of their100     employment;101          (c)  in accordance with a written agreement entered into with the department,102     employees of the Department of Health:103          (i)  whom the director of the Department of Health assigns to conduct scientific studies104     regarding the use or abuse of controlled substances, if the identity of the individuals and105     pharmacies in the database are confidential and are not disclosed in any manner to any106     individual who is not directly involved in the scientific studies; or107          (ii)  when the information is requested by the Department of Health in relation to a108     person or provider whom the Department of Health suspects may be improperly obtaining or109     providing a controlled substance;110          (d)  in accordance with a written agreement entered into with the department, a111     designee of the director of the Department of Health, who is not an employee of the112     Department of Health, whom the director of the Department of Health assigns to conduct113     scientific studies regarding the use or abuse of controlled substances pursuant to an application114     process established in rule by the Department of Health, if:115          (i)  the designee provides explicit information to the Department of Health regarding116     the purpose of the scientific studies;117          (ii)  the scientific studies to be conducted by the designee:118          (A)  fit within the responsibilities of the Department of Health for health and welfare;119          (B)  are reviewed and approved by an Institutional Review Board that is approved for120     human subject research by the United States Department of Health and Human Services; and121          (C)  are not conducted for profit or commercial gain; and122          (D)  are conducted in a research facility, as defined by division rule, that is associated123     with a university or college in the state accredited by the Northwest Commission on Colleges124     and Universities;125          (iii)  the designee protects the information as a business associate of the Department of126     Health; and127          (iv)  the identity of the prescribers, patients, and pharmacies in the database are128     de-identified, confidential, not disclosed in any manner to the designee or to any individual129     who is not directly involved in the scientific studies;130          (e)  in accordance with the written agreement entered into with the department and the131     Department of Health, authorized employees of a managed care organization, as defined in 42132     C.F.R. Sec. 438, if:133          (i)  the managed care organization contracts with the Department of Health under the134     provisions of Section 26-18-405 and the contract includes provisions that:135          (A)  require a managed care organization employee who will have access to information136     from the database to submit to a criminal background check; and137          (B) limit the authorized employee of the managed care organization to requesting either138     the division or the Department of Health to conduct a search of the database regarding a139     specific Medicaid enrollee and to report the results of the search to the authorized employee;140     and141          (ii)  the information is requested by an authorized employee of the managed care142     organization in relation to a person who is enrolled in the Medicaid program with the managed143     care organization, and the managed care organization suspects the person may be improperly144     obtaining or providing a controlled substance;145          (f)  a licensed practitioner having authority to prescribe controlled substances, to the146     extent the information:147          (i) (A)  relates specifically to a current or prospective patient of the practitioner; and148          (B)  is provided to or sought by the practitioner for the purpose of:149          (I)  prescribing or considering prescribing any controlled substance to the current or150     prospective patient;151          (II)  diagnosing the current or prospective patient;152          (III)  providing medical treatment or medical advice to the current or prospective153     patient; or154          (IV)  determining whether the current or prospective patient:155          (Aa)  is attempting to fraudulently obtain a controlled substance from the practitioner;156     or157          (Bb)  has fraudulently obtained, or attempted to fraudulently obtain, a controlled158     substance from the practitioner;159          (ii) (A)  relates specifically to a former patient of the practitioner; and160          (B)  is provided to or sought by the practitioner for the purpose of determining whether161     the former patient has fraudulently obtained, or has attempted to fraudulently obtain, a162     controlled substance from the practitioner;163          (iii)  relates specifically to an individual who has access to the practitioner's Drug164     Enforcement Administration identification number, and the practitioner suspects that the165     individual may have used the practitioner's Drug Enforcement Administration identification166     number to fraudulently acquire or prescribe a controlled substance;167          (iv)  relates to the practitioner's own prescribing practices, except when specifically168     prohibited by the division by administrative rule;169          (v)  relates to the use of the controlled substance database by an employee of the170     practitioner, described in Subsection (2)(g); or171          (vi)  relates to any use of the practitioner's Drug Enforcement Administration172     identification number to obtain, attempt to obtain, prescribe, or attempt to prescribe, a173     controlled substance;174          (g)  in accordance with Subsection (3)(a), an employee of a practitioner described in175     Subsection (2)(f), for a purpose described in Subsection (2)(f)(i) or (ii), if:176          (i)  the employee is designated by the practitioner as an individual authorized to access177     the information on behalf of the practitioner;178          (ii)  the practitioner provides written notice to the division of the identity of the179     employee; and180          (iii)  the division:181          (A)  grants the employee access to the database; and182          (B)  provides the employee with a password that is unique to that employee to access183     the database in order to permit the division to comply with the requirements of Subsection184     58-37f-203[(3)(b)](5) with respect to the employee;185          (h)  an employee of the same business that employs a licensed practitioner under186     Subsection (2)(f) if:187          (i)  the employee is designated by the practitioner as an individual authorized to access188     the information on behalf of the practitioner;189          (ii)  the practitioner and the employing business provide written notice to the division of190     the identity of the designated employee; and191          (iii)  the division:192          (A)  grants the employee access to the database; and193          (B)  provides the employee with a password that is unique to that employee to access194     the database in order to permit the division to comply with the requirements of Subsection195     58-37f-203[(3)(b)](5) with respect to the employee;196          (i)  a licensed pharmacist having authority to dispense a controlled substance to the197     extent the information is provided or sought for the purpose of:198          (i)  dispensing or considering dispensing any controlled substance; or199          (ii)  determining whether a person:200          (A)  is attempting to fraudulently obtain a controlled substance from the pharmacist; or201          (B)  has fraudulently obtained, or attempted to fraudulently obtain, a controlled202     substance from the pharmacist;203          (j)  in accordance with Subsection (3)(a), a licensed pharmacy technician who is an204     employee of a pharmacy as defined in Section 58-17b-102, for the purposes described in205     Subsection (2)(h)(i) or (ii), if:206          (i)  the employee is designated by the pharmacist-in-charge as an individual authorized207     to access the information on behalf of a licensed pharmacist employed by the pharmacy;208          (ii)  the pharmacist-in-charge provides written notice to the division of the identity of209     the employee; and210          (iii)  the division:211          (A)  grants the employee access to the database; and212          (B)  provides the employee with a password that is unique to that employee to access213     the database in order to permit the division to comply with the requirements of Subsection214     58-37f-203[(3)(b)](5) with respect to the employee;215          (k)  federal, state, and local law enforcement authorities, and state and local216     prosecutors, engaged as a specified duty of their employment in enforcing laws:217          (i)  regulating controlled substances;218          (ii)  investigating insurance fraud, Medicaid fraud, or Medicare fraud; or219          (iii)  providing information about a criminal defendant to defense counsel, upon request220     during the discovery process, for the purpose of establishing a defense in a criminal case;221          (l)  employees of the Office of Internal Audit and Program Integrity within the222     Department of Health who are engaged in their specified duty of ensuring Medicaid program223     integrity under Section 26-18-2.3;224          (m)  a mental health therapist, if:225          (i)  the information relates to a patient who is:226          (A)  enrolled in a licensed substance abuse treatment program; and227          (B)  receiving treatment from, or under the direction of, the mental health therapist as228     part of the patient's participation in the licensed substance abuse treatment program described229     in Subsection (2)(m)(i)(A);230          (ii)  the information is sought for the purpose of determining whether the patient is231     using a controlled substance while the patient is enrolled in the licensed substance abuse232     treatment program described in Subsection (2)(m)(i)(A); and233          (iii)  the licensed substance abuse treatment program described in Subsection234     (2)(m)(i)(A) is associated with a practitioner who:235          (A)  is a physician, a physician assistant, an advance practice registered nurse, or a236     pharmacist; and237          (B)  is available to consult with the mental health therapist regarding the information238     obtained by the mental health therapist, under this Subsection (2)(m), from the database;239          (n)  an individual who is the recipient of a controlled substance prescription entered into240     the database, upon providing evidence satisfactory to the division that the individual requesting241     the information is in fact the individual about whom the data entry was made;242          (o)  the inspector general, or a designee of the inspector general, of the Office of243     Inspector General of Medicaid Services, for the purpose of fulfilling the duties described in244     Title 63A, Chapter 13, Part 2, Office and Powers; and245          (p)  the following licensed physicians for the purpose of reviewing and offering an246     opinion on an individual's request for workers' compensation benefits under Title 34A, Chapter247     2, Workers' Compensation Act, or Title 34A, Chapter 3, Utah Occupational Disease Act:248          (i)  a member of the medical panel described in Section 34A-2-601; or249          (ii)  a physician offering a second opinion regarding treatment.250          (3) (a) (i)  A practitioner described in Subsection (2)(f) may designate up to three251     employees to access information from the database under Subsection (2)(g), (2)(h), or (4)(c).252          (ii)  A pharmacist described in Subsection (2)(i) who is a pharmacist-in-charge may253     designate up to three employees to access information from the database under Subsection254     (2)(j).255          (b)  The division shall make rules, in accordance with Title 63G, Chapter 3, Utah256     Administrative Rulemaking Act, to:257          (i)  establish background check procedures to determine whether an employee258     designated under Subsection (2)(g), (2)(h), or (4)(c) should be granted access to the database;259     and260          (ii)  establish the information to be provided by an emergency room employee under261     Subsection (4).262          (c)  The division shall grant an employee designated under Subsection (2)(g), (2)(h), or263     (4)(c) access to the database, unless the division determines, based on a background check, that264     the employee poses a security risk to the information contained in the database.265          (4) (a)  An individual who is employed in the emergency room of a hospital may266     exercise access to the database under this Subsection (4) on behalf of a licensed practitioner if267     the individual is designated under Subsection (4)(c) and the licensed practitioner:268          (i)  is employed in the emergency room;269          (ii)  is treating an emergency room patient for an emergency medical condition; and270          (iii)  requests that an individual employed in the emergency room and designated under271     Subsection (4)(c) obtain information regarding the patient from the database as needed in the272     course of treatment.273          (b)  The emergency room employee obtaining information from the database shall,274     when gaining access to the database, provide to the database the name and any additional275     identifiers regarding the requesting practitioner as required by division administrative rule276     established under Subsection (3)(b).277          (c)  An individual employed in the emergency room under this Subsection (4) may278     obtain information from the database as provided in Subsection (4)(a) if:279          (i)  the employee is designated by the practitioner as an individual authorized to access280     the information on behalf of the practitioner;281          (ii)  the practitioner and the hospital operating the emergency room provide written282     notice to the division of the identity of the designated employee; and283          (iii)  the division:284          (A)  grants the employee access to the database; and285          (B)  provides the employee with a password that is unique to that employee to access286     the database in order to permit the division to comply with the requirements of Subsection287     58-37f-203[(3)(b)](5) with respect to the employee.288          (d)  The division may impose a fee, in accordance with Section 63J-1-504, on a289     practitioner who designates an employee under Subsection (2)(g), (2)(h), or (4)(c) to pay for the290     costs incurred by the division to conduct the background check and make the determination291     described in Subsection (3)(b).292          (5) (a)  An individual who is granted access to the database based on the fact that the293     individual is a licensed practitioner or a mental health therapist shall be denied access to the294     database when the individual is no longer licensed.295          (b)  An individual who is granted access to the database based on the fact that the296     individual is a designated employee of a licensed practitioner shall be denied access to the297     database when the practitioner is no longer licensed.298          Section 3.  Section 58-37f-501 is amended to read:299          58-37f-501. Costs of operating database and recording, submitting, and accessing300     information.301          (1)  All department and division costs necessary to establish and operate the database302     shall be funded by appropriations from:303          (a)  the Commerce Service Account; and304          (b)  the General Fund.305          (2)  All costs associated with recording and submitting [data] information as required in306     this chapter shall be assumed by the submitting pharmacy.307          (3)  All costs associated with accessing the information contained in the controlled308     substance database shall be assumed by the accessing pharmacy, pharmaceutical facility, or309     prescribing practitioner.310          Section 4. Repealer.311          This bill repeals:312          Section 58-37f-801, Pilot program for real-time reporting for controlled substance313     database -- Statewide implementation.314          Section 5.  Appropriation.315          Under the terms and conditions of Title 63J, Chapter 1, Budgetary Procedures Act, for316     the fiscal year beginning July 1, 2015, and ending June 30, 2016, the following sums of money317     are appropriated from resources not otherwise appropriated, or reduced from amounts318     previously appropriated, out of the funds or accounts indicated.  These sums of money are in319     addition to any amounts previously appropriated for fiscal year 2016.320          To Department of Commerce - Division of Occupational and Professional Licensing321               From General Fund$46,000322               Schedule of Programs:323                    Controlled Substance Database               $46,000324          Section 6.  Effective date.325          This bill takes effect on July 1, 2015.Legislative Review Note     as of   2-23-15  4:33 PMOffice of Legislative Research and General Counsel

